SIBP-R002

DRUG2 trials

Sponsors

Shanghai Institute Of Biological Products

Conditions

Asymptomatic HyperuricemiaGout

Phase 1

A Study Exploring Efficacy of Pegloticase in Subjects With Asymptomatic Hyperuricemia

CompletedNCT05302388

Shanghai Institute Of Biological ProductsAsymptomatic Hyperuricemia

Start: 2022-04-11End: 2023-01-09Updated: 2023-12-27

A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout.

RecruitingNCT06298071

Shanghai Institute Of Biological ProductsGout

Start: 2023-03-03End: 2026-12-30Target: 36Updated: 2026-01-08